By silencing USP22, which plays a role in drug resistance, this co-delivery system sensitized HCC cells to Sorafenib, allowing more effective cancer cell apoptosis and improved overall treatment outcomes (Xu et al., 2021). This evidence concerns the gene USP22 and cancer.